Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Amna W. Nasuf; Shalini Ojha; Jon Dorling

doi:10.1002/14651858.CD011921

Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Amna W. Nasuf, Shalini Ojha, Jon Dorling

Research output: Contribution to journal › Article › peer-review

55 Citations (Scopus)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

Original language	English
Article number	CD011921
Journal	Cochrane Database of Systematic Reviews
Volume	2015
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD011921
Publication status	Published - Oct 20 2015
Externally published	Yes

Bibliographical note

Funding Information:
• Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C

Publisher Copyright:
© 2015 The Cochrane Collaboration.

ASJC Scopus Subject Areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD011921

Cite this

@article{fa4f8fd40dc04732bac0713b2227a0e7,

title = "Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother{\textquoteright}s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.",

author = "Nasuf, {Amna W.} and Shalini Ojha and Jon Dorling",

note = "Funding Information: • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",

year = "2015",

month = oct,

day = "20",

doi = "10.1002/14651858.CD011921",

language = "English",

volume = "2015",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

AU - Nasuf, Amna W.

AU - Ojha, Shalini

AU - Dorling, Jon

N1 - Funding Information: • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C Publisher Copyright: © 2015 The Cochrane Collaboration.

PY - 2015/10/20

Y1 - 2015/10/20

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

UR - http://www.scopus.com/inward/record.url?scp=85041672009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041672009&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD011921

DO - 10.1002/14651858.CD011921

M3 - Article

AN - SCOPUS:85041672009

SN - 1361-6137

VL - 2015

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD011921

ER -

Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this